Conquering Diseases

Study Of An Investigational Drug For Late-Stage Ovarian, Peritoneal Or Fallopian Tube Cancer

Description

Seeking women with advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-receptor-alpha expression for a study comparing an investigational drug to chemotherapy.

Overview

We are comparing the investigational drug to standard chemotherapy. Volunteers will be randomly assigned to receive either the investigational drug or the chemotherapy that you and your doctor decide is best for you.

What we're hoping for

Compare an investigational drug to standard chemotherapy for advanced stage gynecological cancers such as ovarian, peritoneal, or fallopian tube cancer. We hope that the investigational drug will target and kill tumor cells.

Additional Information

ClinicalTrials.gov Identifier: NCT04209855

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989